You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Details for New Drug Application (NDA): 020637

✉ Email this page to a colleague

NDA 020637 describes GLIADEL, which is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. Additional details are available on the GLIADEL profile page.

The generic ingredient in GLIADEL is carmustine. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the carmustine profile page.

Summary for 020637

Tradename:	GLIADEL
Applicant:	Azurity
Ingredient:	carmustine
Patents:	0

Pharmacology for NDA: 020637

Mechanism of Action	Alkylating Activity

Medical Subject Heading (MeSH) Categories for 020637

Antineoplastic Agents, Alkylating

Suppliers and Packaging for NDA: 020637

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
GLIADEL	carmustine	IMPLANT;INTRACRANIAL	020637	NDA	Azurity Pharmaceuticals, Inc.	24338-050	24338-050-08	8 POUCH in 1 BOX (24338-050-08) / 1 WAFER in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	IMPLANT;INTRACRANIAL			Strength	7.7MG
Approval Date:	Sep 23, 1996	TE:		RLD:	Yes

Expired US Patents for NDA 020637

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Azurity	GLIADEL	carmustine	IMPLANT;INTRACRANIAL	020637-001	Sep 23, 1996	4,757,128	⤷ Get Started Free
Azurity	GLIADEL	carmustine	IMPLANT;INTRACRANIAL	020637-001	Sep 23, 1996	5,179,189	⤷ Get Started Free
Azurity	GLIADEL	carmustine	IMPLANT;INTRACRANIAL	020637-001	Sep 23, 1996	4,789,724	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.